Nanoparticle-formulated drug combination is effective in medulloblastoma, a pediatric brain tumor January 27, 2022 Dr. Timothy Gershon is co-corresponding author of new research that appeared in Sciences Advances, January 26, 2022.
FDA approves new drug to treat generalized myasthenia gravis January 3, 2022 James F. Howard Jr., MD, professor in the ºÚÁÏÍø Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
Diaz Receives AAN Clinical Research Training Scholarship December 13, 2021 The American Academy of Neurology awarded Monica M. Diaz, MD, MS, a Clinical Research Training Scholarship in support of her research on the detection of neurodegeneration in older, cognitively impaired people with HIV.
James Ho receives Junior Faculty Development Award November 30, 2021 James Pham Ho, MD, receives $10,000 Junior Faculty Development Award
Duke-ºÚÁÏÍø ADRC announces three research funding opportunities November 10, 2021 The Duke/ºÚÁÏÍø ADRC is pleased to announce the release of three funding opportunities for researchers at Duke and ºÚÁÏÍø studying Alzheimer’s disease and related dementias. One of the awards, the REC Scholar, is also open to candidates from ºÚÁÏÍø Pembroke, North Carolina Central University, and East Carolina University.
ºÚÁÏÍø Neurology Receives New Center of Excellence Designation September 1, 2021 The Division of Neuromuscular Disorders has been designated as a GBS|CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and other inflammatory peripheral neuropathies.